NicOx SA (OTCMKTS:NICXF)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $4.82 and traded as low as $4.36. NicOx shares last traded at $4.36, with a volume of 500 shares changing hands.

Separately, Zacks Investment Research cut NicOx from a “buy” rating to a “hold” rating in a report on Friday, July 17th.

The business has a 50 day moving average price of $4.82 and a 200-day moving average price of $4.59.

NicOx Company Profile (OTCMKTS:NICXF)

Nicox SA, an ophthalmic company, researches, develops, and markets therapies that target various ophthalmic conditions in France and internationally. The company's product pipeline includes VyzultaTM, an intraocular pressure-lowering treatment; and NCX 470, a nitric oxide (NO)-donating candidate to treat glaucoma, as well as stand-alone NO donors for specific applications in ophthalmic diseases.

Recommended Story: Why Invest in Dividend Kings

Receive News & Ratings for NicOx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NicOx and related companies with MarketBeat.com's FREE daily email newsletter.